Lipocalin 2 is required for BCR-ABL-induced tumorigenesis

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Lipocalin 2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), is implicated in various biological processes.
• Previous studies suggest LCN2/24p3 plays a role in BCR-ABL-induced myeloid leukemia.
• The precise functions of LCN2 in leukemia pathogenesis require further investigation.

Purpose of the Study:

• To investigate the role of LCN2 (24p3 in mice, NGAL in humans) in BCR-ABL-induced leukemia using mouse bone marrow transplant models.
• To explore the dual functions of LCN2 in normal hematopoietic cell apoptosis and leukemia cell tissue invasion.

Main Methods:

• Utilized mouse bone marrow transplant models with BCR-ABL expressing cells, with and without 24p3/NGAL.
• Employed BCR-ABL+ human CML cell lines (K562) with varying NGAL expression levels.
• Analyzed hematopoiesis suppression, apoptosis rates, spleen atrophy, tumor formation, and plasma LCN2 levels in recipient mice and CML patients.

Main Results:

• BCR-ABL+ cells lacking 24p3 failed to induce leukemia in non-irradiated mice, while wild-type BCR-ABL cells caused CML-like disease.
• High NGAL-secreting K562 cells suppressed hematopoiesis, induced early death, increased apoptosis, and caused spleen atrophy compared to low NGAL cells.
• Elevated plasma LCN2 levels were observed in leukemic mice and CML patients.
• BCR-ABL+ cells from 24p3 null mice did not form solid tumors in nude mice, unlike wild-type counterparts.

Conclusions:

• Lipocalin 2 (LCN2) plays a critical role in BCR-ABL-induced leukemia.
• LCN2 induces apoptosis in normal hematopoietic cells, contributing to disease progression.
• LCN2 facilitates tissue invasion by leukemia cells, promoting tumorigenesis.